CoChat

Glucagon-Like Peptide-1 Receptor Regulates Thromboxane-Induced Human Platelet Activation

Open access
Cahill, Katherine N., Amin, Taneem, Boutaud, Olivier, Printz, Richard, Newcomb, Dawn C., Foer, Dinah, Hodson, David J., Broichhagen, Johannes, Beckman, Joshua A., Yu, Chang, Nian, Hui, Mashayekhi, Mona, Silver, Heidi J., Luther, James M., Brown, Nancy J., Peebles, R. Stokes, Niswender, Kevin · 2022 · JACC: Basic to Translational Science
Cited by 41

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are approved to reduce cardiovascular disease in those with type 2 diabetes mellitus (T2DM). Longer acting GLP-1RAs, liraglutide and semaglutide, demonstrate a signi fi cant reduction in major cardiovascular events not observed in short-acting GLP-1RAs or dipeptidyl peptidase-4 inhibitors. 1 The mechanism by which GLP-1RAs improve cardiovascular risk in T2DM is likely multifactorial with indi-rect effects on platelet aggregation postulated. 1 Platelet activation, independent from hemostasis, contributes to in fl ammation in the cardiovascular system. Prior in vitro studies suggest that GLP-1RAs reduce thrombin-induced platelet aggregation via GLP-1R – independent mechanisms and enhance nitric oxide inhibition of adenosine-, collagen-, and arach-idonic acid – induced platelet aggregation in normo-cholesterolemic states, but no evidence shows a direct GLP-1R effect on platelets. 2 Thromboxane A 2 (TX) is a proin fl ammatory mediator in cardiovascular disease, particularly in T2DM. 3 Patients with T2DM demonstrate elevated platelet TX production and increased urinary TX metabolites. TX is generated by endothelial cells, activated platelets, and macro-phages. It binds the TX receptor on platelets to enhance activation and aggregation. We hypothe-sized that the GLP-1RA liraglutide would directly attenuate TX-induced platelet activation independent of weight loss or changes in glycemic control. for a lack of observed DDP-4 inhibitor effect on TX-induced platelet activation. TX-mediated platelet activation heightens both thrombosis and platelet-mediated in fl ammation. Thus, the GLP-1R may represent a druggable platelet inhibitory receptor relevant in thrombotic and platelet-mediated in fl ammation disease. GLP-1RA – mediated attenuation of platelet activation tone may contribute to the clinical bene fi t observed in cardiovascular outcomes in T2DM. The low doses and short duration of exposure needed to attenuate platelet aggregation in prediabetic adults supports a weight loss – independent clinical bene fi t from GLP-1RAs in cardiovascular disease. This work points toward an expansion of the clinical populations that might bene fi t from treatment. Further study of the relationship between early attenuation of TX-mediated platelet activation following GLP-1RA exposure and thrombotic clinical outcomes are warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacbts.2022.04.004

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 41

Metadata

Authors
Cahill, K. N., Amin, T., Boutaud, O., Printz, R., Newcomb, D. C., Foer, D., Hodson, D. J., Broichhagen, J., Beckman, J. A., Yu, C., Nian, H., Mashayekhi, M., Silver, H. J., Luther, J. M., Brown, N. J., Peebles, R. S., & Niswender, K.
Venue
JACC: Basic to Translational Science
Publisher
Elsevier BV
Published
2022-07
Volume
7
Issue
7
Pages
713-715
ISSN
2452-302X (ISSN-L)
OpenAlex
W4287843575
Cited by
41
References
1
FWCI
4.53
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucagon-Like Peptide-1 Receptor Regulates Thromboxane-Induced Human Platelet Activation. https://app.cochat.ai/papers/10.1016/j.jacbts.2022.04.004
The paper
Cahill, K. N., Amin, T., Boutaud, O., Printz, R., Newcomb, D. C., Foer, D., Hodson, D. J., Broichhagen, J., Beckman, J. A., Yu, C., Nian, H., Mashayekhi, M., Silver, H. J., Luther, J. M., Brown, N. J., Peebles, R. S., & Niswender, K. (2022). Glucagon-Like Peptide-1 Receptor Regulates Thromboxane-Induced Human Platelet Activation. JACC: Basic to Translational Science. https://doi.org/10.1016/j.jacbts.2022.04.004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.